Leave Your Message

Sustainable Endotoxin Testing in China: Chromogenic Assay by Leading Suppliers and Factory for Reliable Results

rCR (Recombinant Cascade Reagents) are innovative, animal-free solutions designed for Bacterial Endotoxin Testing (BET). Composed of recombinant Factor C, Factor B, and pro-clotting enzyme, rCR effectively mimics the LAL enzymatic cascade while eliminating interference from Factor G and (1→3)-β-D-glucan. In chromogenic assays, the presence of endotoxin activates Factor C, leading to a sequence of reactions that generate a colorimetric signal directly proportional to endotoxin levels, with an impressive sensitivity of 0.001 EU/mL. Fully compliant with USP (2025), our rCR products seamlessly integrate into standard BET platforms without requiring any hardware modifications. As a leading supplier in China, we ensure sustainable, high-performance, and globally reliable endotoxin detection solutions suitable for pharmaceuticals, medical devices, and water testing. Trust our factory for your next-generation endotoxin testing needs

    Products Features

    The Recombinant Cascade Reagent (RCR) represents a significant advancement in bacterial endotoxin testing, serving as a sustainable and highly specific recombinant alternative to traditional Limulus Amoebocyte Lysate (LAL). Its development aligns with modern ethical and regulatory expectations while maintaining robust analytical performance.

    Animal-Free & Sustainable

    Utilizes recombinant technology to eliminate dependency on horseshoe crab blood, supporting conservation efforts and promoting animal welfare without compromising reagent supply.

    Native Cascade Mechanism

    Comprising recombinant Factor C, Factor B, and proclotting enzyme, the reaction mechanism closely mirrors native LAL, ensuring high correlation with conventional methods.

    Enhanced Specificity

    Not activated by (1→3)-β-D-glucans, eliminating false-positive results and significantly improving test accuracy and reliability in complex pharmaceutical matrices.

    Regulatory Compliance

    Supported by emerging pharmacopeial standards, such as the proposed USP <86> chapter, facilitating smooth adoption in regulated laboratory environments.

    Finally, the applicability of RCR has been demonstrated across a range of real-world pharmaceutical products, where it has exhibited excellent sample compatibility and produced results comparable to those obtained with traditional LAL-based methods. This proven performance, combined with its ethical and regulatory advantages, positions RCR as a modern and responsible choice for endotoxin testing in the pharmaceutical industry.

    Frequently Asked Questions

    Q: What is Recombinant Cascade Reagent (RCR)?

    RCR is a sustainable and highly specific recombinant alternative to traditional Limulus Amoebocyte Lysate (LAL) used for bacterial endotoxin testing in the pharmaceutical industry.

    Q: How does RCR contribute to animal welfare and conservation?

    By utilizing recombinant technology, RCR is produced through an entirely animal-free process. This eliminates the dependency on horseshoe crab blood, supporting global conservation efforts.

    Q: Does RCR perform similarly to traditional LAL methods?

    Yes. RCR contains recombinant Factor C, Factor B, and proclotting enzyme, creating a cascade reaction mechanism that closely mirrors native LAL and delivers highly comparable results.

    Q: How does RCR prevent false-positive results?

    Unlike native LAL, RCR is not activated by (1→3)-β-D-glucans, which are common sources of false-positives, thereby improving test accuracy in complex sample matrices.

    Q: Is RCR recognized by regulatory pharmacopeial standards?

    Yes, its adoption is supported by emerging standards such as the proposed USP <86> chapter, "Bacterial Endotoxins Test Using Recombinant Reagents," facilitating its use in regulated environments.